Derek Louis Sammann - 15 Mar 2026 Form 4 Insider Report for CME GROUP INC. (CME)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
17 Mar 2026, 12:23:30 UTC
Prior SEC filing
21 Nov 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: Margaret Austin Wright For: Derek Louis Sammann

Key filing fact

Derek Louis Sammann filed Form 4 for CME GROUP INC. (CME) on 17 Mar 2026.

Key facts

  • This page summarizes Derek Louis Sammann's Form 4 filing for CME GROUP INC. (CME).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Mar 2026, 12:23.

Change

  • Previous filing in this sequence was filed on 21 Nov 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001475318 Primary reporting owner

Sammann Derek

Relationship
Sr MD Gl Hd Commodities Mkts
Address
20 S. WACKER DRIVE, CHICAGO
Signature
By: Margaret Austin Wright For: Derek Louis Sammann
Signature date
17 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CME transaction

Common Stock Class A

Award

Transaction value
Shares
+8,256
Change %
+95%
Price
$311.40*
Shares after
16,939
Date
15 Mar 2026
Ownership
Direct
Footnotes
F1
CME transaction

Common Stock Class A

Tax liability

Transaction value
Shares
-3,627
Change %
-21%
Price
$311.40*
Shares after
13,312
Date
15 Mar 2026
Ownership
Direct
Footnotes
F2
CME holding

Common Stock Class A

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
11,028
Date
15 Mar 2026
Ownership
by Trust
CME holding

Common Stock Class A

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
7,022
Date
15 Mar 2026
Ownership
by Spouse
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025.

Footnote F2

Mr. Sammann surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .